(Iso)-Dehydroemetine

CAS No. 2649-50-5

(Iso)-Dehydroemetine( —— )

Catalog No. M36071 CAS No. 2649-50-5

(Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 340 Get Quote
5MG 273 Get Quote
10MG 372 Get Quote
25MG 563 Get Quote
50MG 742 Get Quote
100MG 977 Get Quote
200MG 1293 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Iso)-Dehydroemetine
  • Note
    Research use only, not for human use.
  • Brief Description
    (Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.
  • Description
    (Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2649-50-5
  • Formula Weight
    478.62
  • Molecular Formula
    C29H38N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C=1C[C@]2(C=3C(=CC(OC)=C(OC)C3)CCN2CC1CC)[H])[C@H]4C=5C(=CC(OC)=C(OC)C5)CCN4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Jasmone

    Jasmone is a natural product isolated from the volatile portion of the oil from jasmine flowersas an insect semiochemical and in plant defense.

  • (Rac)-5-Keto Fluvast...

    (Rac)-5-Keto Fluvastatin is an impurity of Fluvastatin. Fluvastatin is an inhibitor of HMG-CoA reductase(IC50 of 8 nM).

  • Citreorosein

    Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.